Actively Recruiting
Regulation of Inflammatory Genes in Psoriasis
Led by University of Alabama at Birmingham · Updated on 2026-04-06
13
Participants Needed
1
Research Sites
731 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Psoriasis is a chronic and recurrent skin disorder characterized by marked inflammatory changes in the skin. An extensive cytokine network including generated by activated dendritic cells and T cells mediates the formation of psoriatic lesions. These immune-response parameters can be used as markers in the severity and management of the disease after further in-depth studies.
CONDITIONS
Official Title
Regulation of Inflammatory Genes in Psoriasis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Clinical diagnosis of psoriasis
- Age 19 years or older
- Fitzpatrick skin type I, II, III, IV, V, or VI
You will not qualify if you...
- No photosensitive disease and not taking photosensitizing medications
- History of keloids or likely to develop hypertrophic scars after skin biopsy
- Allergy to local anesthetics, antibiotics, or anticoagulants
- Pregnancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The Kirklin Clinic
Birmingham, Alabama, United States, 35294
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here